Parabilis raised $670M in the largest venture-backed biotech IPO, topping Kailera's $625M April debut after a decade of building through...
Parabilis raised $670M in the largest venture-backed biotech IPO, topping Kailera's $625M April debut after a decade of building through the biotech winter.
